9d4b21c6-35a8-4ce7-97b5-772a310620b6
  • The Firm
    • The Firm
      • Overview
      • Our People
      • Our Clients
  • Our Offices
  • Press Releases
  • Our Businesses
    • Our Businesses
      • Private Equity
      • Real Estate
      • Credit (GSO)
      • Hedge Fund Solutions (BAAM)
      • Strategic Partners
      • Tactical Opportunities
      • Infrastructure
      • Insurance Solutions
      • Life Sciences
      • Innovations
      • Registered Products
  • Our Impact
    • Blackstone Charitable Foundation
      • Overview
    • Corporate Social Responsibility
      • Overview
  • Insights
  • Careers
    • Careers
      • Why Blackstone
      • Diversity & Inclusion
  • LP Login
  • Shareholders
  • Legal Links
    • Transparency & Disclosure
    • Legal
    • Privacy
    • Cookie Policy (EU)
    • Japan Disclaimer
  • Contact Us
  • PWS Rebrand
    • BXMIX-ReRebrand
      • Page Sections
        • Why Blackstone Alt Multi‑Strategy Fund
        • Why Blackstone
        • Why Multi-Manager
        • Why Alternative Strategies
        • Performance
        • Literature
        • Important Risks
      • Other Blackstone Strategies
        • Breit
        • Bgfrei
        • Bxdms
LP Login
  • NIBC and Blackstone agree on an amended recommended all-cash public offer for all NIBC shares

    Jul 13, 2020, 03:32 AM by Rebecca Flower
    NIBC and the Offeror have reached conditional agreement on an amended recommended all-cash public offer for all issued and outstanding shares in the capital of NIBC.
    Full story
  • Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund

    Jul 9, 2020, 15:40 PM by David Vitek
    Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the inaugural Blackstone fund in Life Sciences. BXLS V was oversubscribed and closed at its hard cap of $4.6 billion of total capital commitments — the largest life sciences private fund raised to date.
    Full story
  • Blackstone Announces Second Quarter 2020 Investor Call

    Jul 1, 2020, 16:17 PM by David Vitek
    Blackstone (NYSE:BX) announced today that it will host its second quarter investor conference call via public webcast on July 23, 2020 at 9:00 a.m. ET.
    Full story
  • Hudson Pacific Properties and Blackstone Announce New Joint Venture to Expand Studio Platform

    Jun 29, 2020, 09:01 AM by Serena Bancroft
    Hudson Pacific Properties, Inc. (“Hudson Pacific”) (NYSE: HPP) and Blackstone (NYSE: BX) today announced that funds affiliated with Blackstone Property Partners will acquire a 49% interest in Hudson Pacific’s three Hollywood studios and five on-lot or adjacent Class A office properties, totaling 2.2 million square feet, at a gross portfolio valuation of $1.65 billion.
    Full story
  • Ruth Porat, Alphabet and Google CFO, Joins Blackstone’s Board of Directors

    Jun 25, 2020, 08:13 AM by Emma Quigley
    Ruth Porat, Alphabet and Google CFO, Joins Blackstone’s Board of Directors
    Full story
  • Blackstone Announces Appointment of Dr. Ulrich Spiesshofer as Senior Advisor

    Jun 23, 2020, 01:04 AM by Alexandra Ritterman
    London, June 23 2020 - Blackstone (NYSE:BX) today announced the appointment of Dr. Ulrich Spiesshofer, former President and Chief Executive Officer of ABB Ltd, as Senior Advisor.
    Full story
  • Medtronic Announces a $337 Million Product Investment from Blackstone Life Sciences to Expand Development of Future Diabetes Technologies

    Jun 12, 2020, 17:33 PM by David Vitek
    Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development (R&D) funding in its Diabetes Group through an agreement to receive $337 million of funding from funds managed by Blackstone Life Sciences (“BXLS”) including co-investors, aimed at advancing new, innovative products especially designed to reduce the burden of diabetes management.
    Full story
  • Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic Investment

    Jun 11, 2020, 07:36 AM by David Vitek
    Blackstone (NYSE: BX) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata”), a clinical-stage biopharmaceutical company, today announced that funds managed by Blackstone Life Sciences (“BXLS”) will lead a $350 million royalty and equity investment in Reata to fund the development and potential commercialization of bardoxolone methyl (“bardoxolone”), an investigational once-daily oral therapy being studied for chronic kidney disease (“CKD”) in Alport syndrome, autosomal dominant polycystic kidney disease (“ADPKD”), and other associated potential future indications.
    Full story
  • 8 June 2020: Further update on public offer for all NIBC shares

    Jun 8, 2020, 02:02 AM by Rebecca Flower
    Full story
  • Blackstone Commits Nearly $600,000 to Support COVID-19 Relief Efforts in Singapore

    Jun 5, 2020, 08:24 AM by David Vitek
    Blackstone Singapore announced today a donation of nearly $600,000 to Community Chest, the fundraising and engagement arm of the National Council of Social Service. The contribution will provide assistance for vulnerable members of the community impacted by the COVID-19 outbreak and includes funding from Blackstone Singapore, its employees and the Blackstone Charitable Foundation.
    Full story
  • Blackstone Announces Appointment of Dr. Mark McClellan, Former Head of the FDA and CMS, as Senior Advisor

    May 29, 2020, 11:56 AM by Serena Bancroft
    Blackstone (NYSE:BX) today announced the appointment of Dr. Mark McClellan (MD, PhD), a physician and economist who served as both the commissioner of the U.S. Food and Drug Administration (FDA) and administrator of the Centers for Medicare & Medicaid Services (CMS), as a Senior Advisor.
    Full story
  • Blackstone to Present at the Morgan Stanley Virtual US Financials Conference

    May 28, 2020, 09:04 AM by Serena Bancroft
    Blackstone (NYSE:BX) announced today that Jon Gray, President & Chief Operating Officer, is scheduled to present at the Morgan Stanley Virtual US Financials Conference on Wednesday, June 10, 2020 at 12:00 pm ET.
    Full story
  • Further update on public offer for all NIBC shares

    May 18, 2020, 15:38 PM by Rebecca Flower
    Full story
  • Blackstone to Present at Bernstein’s 36th Annual Strategic Decisions Conference

    May 12, 2020, 10:32 AM by David Vitek
    Blackstone (NYSE: BX) announced today that Stephen Schwarzman, Chairman, CEO and Co-Founder, is scheduled to present virtually at Bernstein’s 36th Annual Strategic Decisions Conference on Wednesday, May 27, 2020 at 1:30PM ET.
    Full story
  • Blackstone Hires Vini Letteri as a Senior Managing Director for Growth Equity Investing

    May 5, 2020, 10:28 AM by Serena Bancroft
    Blackstone (NYSE: BX) announced that Vini Letteri will join Blackstone Growth (“BXG”), the firm’s recently launched global growth equity investing platform. He will be a Senior Managing Director and brings two decades of experience as a seasoned growth equity investor and operations professional.
    Full story
  • Update on public offer for all NIBC shares

    Apr 28, 2020, 01:30 AM by Rebecca Flower
    Full story
  • Blackstone Reports First Quarter 2020 Results

    Apr 23, 2020, 07:05 AM by Emma Quigley
    Blackstone will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. ET.
    Full story
  • Blackstone Announces First Quarter 2020 Investor Call

    Apr 13, 2020, 16:19 PM by David Vitek
    Blackstone (NYSE:BX) announced today that it will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. EST.
    Full story
  • Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics

    Apr 13, 2020, 07:37 AM by David Vitek
    Blackstone and Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the companies have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support Alnylam’s advancement of innovative RNA interference (RNAi) medicines that have the potential to transform the lives of patients suffering from a range of debilitating diseases.
    Full story
  • Blackstone Completes Acquisition of HealthEdge Software, a Leading Healthcare Technology Solutions Provider

    Apr 9, 2020, 12:56 PM by Serena Bancroft
    New York – April 9, 2020, Blackstone (NYSE:BX) announced today that funds managed by Blackstone ("Blackstone") have completed their previously announced acquisition of a majority stake in HealthEdge Software (“HealthEdge”), a leading healthcare technology company that delivers next generation Core Administrative Processing Systems (CAPS) solutions to customers across the healthcare ecosystem.
    Full story
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links
Explore Blackstone
Get in Touch
  • Limited Partner Login
  • Contact Us
Back to Top
Blackstone
© 2016 The Blackstone Group Inc. | English | 中文 (Chinese)
Transparency & Disclosure | Legal | Privacy | Cookie Notice | Japan Disclaimer
プライバシー・ポリシー  | 法規制に基づく開示

ブラックストーン・グループ・ジャパン株式会社

金融商品取引業者 関東財務局(金商)第1785号

加入協会/日本証券業協会 一般社団法人第二種金融商品取引業協会

Stay up-to-date

Email Alerts

To receive email notifications when press releases or Byron Wien's Market Commentaries are posted, sign up for email alerts here.

 

Cookie Information and Consent Request

Blackstone Cookie Policy

This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Please click on the link "Learn More" if you would like more information about the cookies used on this website and how to change your cookie settings. Otherwise, we will assume you're OK to continue.

Learn More

I am fine to continue
×

Contact Us

General

For office-specific contact information, please visit our offices page.
Switchboard: +1 (212) 583-5000


Media Contacts

For press inquiries please call or email:
 +1 212-583-5263
 PressInquiries@Blackstone.com


Email Alerts & Investor Relations

To receive email notifications when press releases or Byron Wien’s Market Commentaries are posted, sign up for email alerts here.

For investor relations contact information or to receive email notifications for SEC filings, events, end of day stock quotes, and financial reports, please visit our Investor Relations page.

Investor Relations Contact Information

 US: +1 888-756-8443
 International: +1 646-313-6590
 BlackstoneInvestorRelations@blackstone.com